Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-inflammatory medication in cataract surgery of pseudoexfoliation eyes
2016-004784-40Phase 4Completed
- Sponsor
- Raimo Tuuminen
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in senile cataract (ARC) and pseudoexfoliation syndrome (PXF) comparing Nevanac arm with Pred Forte arm (2 arms). Primary endpoints: Best corrected visual acuity and Central retinal parameters. Started Jan 2017; status: completed.
02
Drugs
nepafenacprednisolone
03
Conditions
senile cataract (ARC)pseudoexfoliation syndrome (PXF)
Beyond the preview
Go deeper on 2016-004784-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004784-40.